Literature DB >> 2308895

Method validation revisited: a chemometric approach.

M J Cardone1, S A Willavize, M E Lacy.   

Abstract

A validation procedure is presented that satisfies the FDA requirements of accuracy (including precision repeatability), sensitivity, linearity, dynamic range, and homoscedasticity, all with a single set of data. The procedure utilizes the corrigible error correction (CEC) technique comprised of three response curves--standard, Youden one-sample, and method of standard additions (MOSA) plots, from a total of 15 to 18 X,Y data pairs. For the bias component of accuracy, the systematic bias error of the method is quantitatively separated into its constant and proportional error components. The overall constant systematic error is further separated into the system (blank) and analyte-matrix (sample) components. The CEC data also provide an internal, i.e., in situ corrected assay for the sample for comparison with alternative method data. Statistical diagnostic tests are used for the final evaluation of the method acceptability, specifically in deciding whether or not the systematic error indicated requires a root source search for its removal or is simply a calibration constant of the method.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308895     DOI: 10.1023/a:1015876718419

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  3 in total

1.  Measuring and maximizing precision in analyses based on use of calibration graphs.

Authors:  D G Mitchell; J S Garden
Journal:  Talanta       Date:  1982-11       Impact factor: 6.057

2.  Quantitative evaluation of linearity.

Authors:  R W Burnett
Journal:  Clin Chem       Date:  1980-04       Impact factor: 8.327

3.  More on quantitative evaluation of linearity.

Authors:  R F Martin
Journal:  Clin Chem       Date:  1980-09       Impact factor: 8.327

  3 in total
  1 in total

1.  Analytical method comparison based upon statistical power calculations.

Authors:  D J Mazzo; M Connolly
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.